Bevatas 400 mg Injection Bevatas 400 mg/16 mL Injection contains bevacizumab, a targeted anticancer medicine used to treat several types of advanced and metastatic cancers. It works by blocking vascular endothelial growth factor (VEGF), a protein that helps tumors develop new blood vessels. By reducing the blood supply to cancer cells, the medicine helps slow tumor growth and limits the spread of the disease.

Effects & Benefits Helps slow the growth and spread of certain cancers. Reduces the formation of new blood vessels that supply nutrients to tumors. Supports the treatment of colorectal, lung, kidney, ovarian, cervical, and selected brain cancers. May improve treatment outcomes when used together with chemotherapy or other anticancer therapies. Helps delay disease progression in eligible patients. Supports long-term disease management under the supervision of an oncology specialist. Possible Side Effects

Like all medicines, Bevatas 400 mg/16 mL Injection may cause side effects, although not everyone experiences them